FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

First-Time Generics - January 2009

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 ALPRAZOLAM ORALLY DISINTEGRATING TABLETS, 0.25 MG, 0.5 MG, 1 MG AND 2 MG     KALI LABORATORIES, INC. NIRAVAM ORALLY DISINTEGRATING TABLETS 1/9/2009 
2 LEVETIRACETAM ORAL SOLUTION, 100 MG/ML        ACTAVIS MID ATLANTIC LLC KEPPRA ORAL SOLUTION 1/15/2009 
3 LEVETIRACETAM ORAL SOLUTION, 100 MG/ML        AUROBINDO PHARMA LTD KEPPRA ORAL SOLUTION, 100 MG/ML 1/15/2009 
4 LEVETIRACETAM ORAL SOLUTION, 100 MG/ML        TOLMAR INC. KEPPRA ORAL SOLUTION 1/15/2009 
5 LEVETIRACETAM ORAL SOLUTION, 100 MG/ML        ROXANE LABORATORIES, INC. KEPPRA ORAL SOLUTION 1/15/2009 
6 DIVALPROEX SODIUM DELAYED RELEASE CAPSULES (SPRINKLE), 125 MG (VALPROIC ACID EQUIVALENT)        DR. REDDY'S LABORATORIES, INC. DEPAKOTE SPRINKLE CAPSULES, 125 MG 1/23/2009 
7 DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS, 250 MG AND 500 MG       MYLAN PHARMACEUTICALS, INC. DEPAKOTE ER TABLETS, 250 MG AND 500 MG 1/29/2009 
8 RISPERIDONE ORAL SOLUTION, 1 MG/ML        TEVA PHARMACEUTICALS USA RISPERDAL ORAL SOLUTION 1/30/2009 
9 GALANTAMINE HYDROBROMIDE ORAL SOLUTION, 4 MG/ML        ROXANE LABORATORIES, INC. RAZADYNE ORAL SOLUTION 1/30/2009 

Back to Top      Back to Approvals

Date created: February 3, 2009
horizonal rule

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research